The EMA's human medicines committee, the CHMP, has recommended approval of Eli Lilly's oral GLP-1 agonist Foundayo for weight ...
City Therapeutics has finalised its IPO, raising $200 million for a pipeline of RNA interference (RNAi) therapies headed by a ...
Although real progress has been made in managing depression over recent decades, significant hurdles remain. In fact, around ...
The CHMP has backed Rasonque (daraxonrasib) for adults with metastatic pancreatic adenocarcinoma who have received at least ...
"Treating thyroid eye disease requires balancing efficacy, safety, and the practical realities of long-term treatment," said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results